Deciphering the redox chemistry of physical plasma-treated clinically-relevant liquids as novel therapy against ovarian cancer
Implementing Organization
Principal Investigator
Dr. Naresh Kumar
Ramalingaswami fellow
|
National Institute Of Pharmaceutical Education And Research (Niper-G)
CO-Principal Investigator
Dr. BidyaDhar Sahu
National Institute Of Pharmaceutical Education And Research (Niper-G)
About
This project aims to identify the optimal tumor-toxic target chemistry of plasma-treated liquids (PTL) as anticancer agents. The project will use clinically-relevant liquids and experimental methods to optimize plasma redox chemistry. The PTLs will be tested in vitro for efficacy in treating metastatic ovarian cancer, a common cancer in young women. The molecular basis of anticancer PTL redox effects will be investigated, and the best plasma condition will be investigated for pre-clinical impact. The novel redox-active PTL approach will be tested in mice.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Ramalingaswami fellow
National Institute Of Pharmaceutical Education And Research (Niper-G)
Acces sibility Controls